# William Jacot

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-jacot/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,244 |
| Field | Advanced Breast Cancer Therapies |
| h-index | 52 |
| i10-index | 177 |
| Last Known Institution | Institut de Recherche en Cancérologie de Montpellier |
| OpenAlex ID | https://openalex.org/A5053668514 |
| ORCID iD | https://orcid.org/0000-0001-7834-061X |
| Works | 475 |

## Researcher papers

- [Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-emtansine-for-residual-invasive-her2-positive-breast-cancer/)
- [Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer](https://scholariq.org/papers/trastuzumab-deruxtecan-in-previously-treated-her2-low-advanced-breast-cancer/)
- [Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials](https://scholariq.org/papers/trastuzumab-for-early-stage-her2-positive-breast-cancer-a-meta-analysis-of-13/)
- [Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer](https://scholariq.org/papers/full-length-cytokeratin-19-is-released-by-human-tumor-cells-a-potential-role-in/)

## Researcher topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Institut de Recherche en Cancérologie de Montpellier](https://scholariq.org/institutions/institut-de-recherche-en-cancerologie-de-montpellier/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.